Research Applications of Combigan Eye Drops
Combigan is a pharmaceutical ophthalmic solution formulated by Allergan containing two active ingredients: brimonidine tartrate 0.2% and timolol maleate 0.5%. This dual-action formulation represents a sophisticated approach to studying glaucoma pathophysiology in laboratory settings. Researchers examining ocular pressure regulation mechanisms frequently investigate this combination therapy to understand how alpha-2 adrenergic agonists work synergistically with beta-blockers in intraocular pressure modulation studies.
The formulation allows researchers to study complementary mechanisms of action within a single preparation. Brimonidine tartrate functions as an alpha-2 adrenergic receptor agonist, while timolol maleate acts as a non-selective beta-adrenergic receptor antagonist. This combination provides scientists with an opportunity to examine dual-pathway intervention strategies in glaucoma research models. Laboratory studies often evaluate how these mechanisms interact to produce enhanced efficacy compared to monotherapy approaches.
Pharmaceutical Research Specifications
Leading research institutions routinely procure this formulation from Stroid UK Shop for their ophthalmology research programmes. The sterile ophthalmic solution maintains pharmaceutical-grade standards essential for laboratory applications. Research teams investigating intraocular pressure dynamics often compare this combination therapy against individual component studies. The preservative system and buffering agents in this formulation provide additional research parameters for scientists examining ocular drug delivery mechanisms.
| Parameter | Value |
|---|---|
| Brimonidine Concentration | 0.2% w/v |
| Timolol Concentration | 0.5% w/v |
| Formulation Type | Sterile ophthalmic solution |
| Manufacturer | Allergan |
| Storage Requirements | 2-25°C, protect from light |
Laboratory Applications and Research Context
Research facilities studying other drugs often include this ophthalmic formulation in comparative studies with SARMs and peptides to understand different therapeutic mechanisms. The dual-action profile makes it particularly valuable for research examining receptor selectivity and tissue-specific responses. Laboratory protocols frequently incorporate this preparation when investigating ocular pharmacokinetics and the relationship between systemic and local drug effects.
Disclaimer: This product is strictly intended for in-vitro research and laboratory applications only. Not approved for human consumption, therapeutic use, or clinical applications. Researchers must comply with all applicable safety regulations and institutional guidelines when handling this material.
